All Articles

Oculis is advancing a neuroprotective drug for optic neuropathies and a first-of-its-kind eye drop for diabetic macular edema, aiming at $10B+ markets.

A newly validated genetic test accurately predicts melanoma risk, offering a non-invasive alternative to the standard surgical biopsy for many patients.

After a major win at CES 2026, a South Korean edtech firm is set to bring its revolutionary 'Visual LLM' learning platform to the US K-12 market.

Renowned scientist Eric Hoek becomes Executive Chairman at Active Membranes, aiming to commercialize a technology that could cut water treatment costs by 50%.

Pharma giant Bayer partners with biotech innovator Soufflé to develop a groundbreaking siRNA therapy, aiming to deliver genetic medicine directly to the heart.

The UK retail giant is ditching manual spreadsheets for an AI-driven platform to standardize labor and enhance customer experience across 240+ stores.

After success in Europe, Allotex gets FDA nod to begin U.S. trials for its tissue-based presbyopia treatment, offering new hope for millions.

A new clinical benchmark published in a Nature journal reveals a Chinese AI is the safest and most effective, challenging Silicon Valley's dominance.

At CES 2026, BLUETTI moves beyond portable power, unveiling smart home batteries, a sodium-ion first, and a vision for a decentralized energy grid.

At CES 2026, RobotEra's L7 humanoid and 'Hexa-Core' lineup showcase China's growing dominance in the global robotics race. Here's a deep dive.

At CES 2026, LumiMind's BCI tech promises to guide you to sleep and power thought-controlled games, raising major scientific and ethical questions.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

Fresh off a CES 2026 Innovation Award win, ULS Robotics' new VIATRIX™ exoskeleton promises to bring industrial-strength assistance to everyday adventurers.

Beyond the hype, X-Humanoid's robots are running marathons and working on production lines, signaling a major shift from lab demos to real-world deployment.

Ahrefs expands its Brand Radar to track YouTube, TikTok, and Reddit, aiming to give marketers a unified view of brand discovery in the age of AI.

At CES 2026, new optical engines from Appotronics promise to make AR glasses as light as normal eyewear, sparking a race toward an affordable, all-day wearable future.

Amid rising virtualization costs, Arcfra's partnership with Netfos introduces a new, AI-ready cloud alternative for Taiwan's tech-driven enterprises.

CES 2026: A new platform, Liquid Canvas, aims to liberate digital art from brand-locked TVs, offering a universal subscription for any screen.

Biotech leader Arrowhead Pharmaceuticals prices upsized offerings, signaling strong investor confidence and fueling its next wave of RNAi therapies.

The Michigan-based firm moves beyond asset disposal, launching end-to-end services to help organizations cut costs, boost efficiency, and secure data.